Phillips 66 enters the back half of May with its most bullish analyst signal in months — but the options market still hasn't fully stood down.
Goldman Sachs moved first this morning. Analyst Neil Mehta raised his price target on PSX to $207 from $192, maintaining a Neutral rating — a notable lift that pushes Goldman's target well above the current $182.38 close. The move follows a broader wave of upward revisions. Since late March, every firm in coverage has raised targets: UBS holds the highest at $212, Wells Fargo at $201, Raymond James at $205. Morgan Stanley upgraded to Overweight in late April. The consensus mean has climbed to $187.42, and the analyst recommendation divergence factor ranks in the 87th percentile — meaning the gap between current price and Street targets is wider than most stocks in the universe right now. The Street has been consistently chasing the stock higher, not ahead of it.
Options positioning tells a more cautious story, though the pressure has eased from its peak. The put/call ratio closed Tuesday at 0.96 — still 2.6 standard deviations above its 20-day mean of 0.89, and the most elevated reading of the past year outside the 52-week high of 1.22. That's elevated demand for downside protection on a stock up 16.6% in a month. Earlier this week an article noted the same dynamic: bears were circling the rally. What's changed is that short interest pulled back sharply on May 19, dropping 5.9% in a single session to 6.9 million shares, or 1.71% of free float — reversing a spike to 7.3 million on May 18. The short score edged down to 30.4 from a recent peak of 31.4. The borrow market itself offers no ammunition to bears: availability is effectively unlimited, with cost to borrow at just 0.29% and falling over the past month.
The bull case centers on midstream. Goldman's raise and the broader analyst consensus reflect confidence that PSX's midstream segment — roughly 40% of 2025 EBITDA — will deliver $500 million of incremental EBITDA growth over two years, with acquisitions and organic projects compounding the base. EPS momentum scores in the 78th percentile on a 30-day basis and 74th on 90 days, suggesting estimate revisions are still moving in the right direction. Valuation is undemanding: the stock trades at 11x trailing earnings and 7.7x EV/EBITDA, with price-to-book at 2.16x. The dividend score ranks in the 93rd percentile. Bears point to margin exposure — refining cracks remain volatile — and question whether the midstream re-rating thesis is already priced in after a 36% year-to-date run.
Peer performance confirms the energy tape is broadly supportive. VLO gained 6.3% on the week, XOM added 7.9%, and closest peer MPC rose 4.4%. PSX at +4.0% on the week broadly matched the group, suggesting no idiosyncratic catalyst — the move is sector-driven rather than stock-specific. The CFO's sale of nearly 30,000 shares at $170 on May 8 is worth noting: it registered while the stock was trading below current levels, and the 90-day net insider position is actually positive at roughly $33 million sold against a small buy, a pattern consistent with routine executive selling rather than a directional signal.
The next print is July 30. Between now and then, the key watch is whether the put/call ratio normalises back toward its 0.89 mean as the rally consolidates — or holds elevated, signalling that options traders see something the analysts don't.
See the live data behind this article on ORTEX.
Open PSX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
